Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French multicenter registry

Circulation

Volumn 94, Issue 7, 1996, Pages 1519-1527

  Karrillon, Gaëtan J ^a   Morice, Marie Claude ^b   Benveniste, Edgar ^b   Bunouf, Pierre ^b   Aubry, Pierre ^b   Cattan, Simon ^b   Chevalier, Bernard ^b   Commeau, Philippe ^b   Cribier, Alain ^b   Eiferman, Charles ^b   Grollier, Gilles ^b   Guerin, Yves ^b   Henry, Michel ^b   Lefevre, Thierry ^b   Livarek, Bernard ^b   Louvard, Yves ^b   Marco, Jean ^b   Makowski, Serge ^b   Monassier, Jean Pierre ^b   Pernes, Jean Marc ^b   Rioux, Philippe ^b   Spaulding, Christian ^b   Zemour, Gilles ^b   more..

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^b NONE

Author keywords

aspirin; coronary artery; stents; ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECHOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; STENT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 10144234792     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1519     Document Type: Article

References (25)

1. Herrmann HC, Buchbinder M, Clemen M, Fishman D, Goldberg S, Leon MB, Schatz RA, Tierstein P, Walker CM, Hirshfeld JW. Emergent use of balloon-expandable stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 1992;86:812-819.
2. George BS, Voorhees WD III, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB III, Holmes DR, Topol ER, Kereiakes DJ, Hartzler GO. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol. 1993;22:135-143.
3. Hearn JA, King SB III, Douglas JS Jr, Carlin SF, Lembo NJ, Ghazzal ZM. Clinical and angiographie outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal angioplasty: initial results with a balloon expandable, stainless steel design. Circulation. 1993;88:2086-2096.
4. Fischman DL, Leon MB, Baim D, Schatz RA, Penn I, Detre K, Savage MP, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein P, Fish D, Colombo A, Brinker J, Moses J, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994; 331:496-501.
5. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy J-J, Van den Huevel P, Delcan J, Morel MA, for the BENESTENT Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331: 489-495.
6. Sutton JM, Ellis SG, Roubin GS, Pinkerton CA, King SB III, Raizner AE, Holmes DR, Kereiakes DJ, Topol EJ. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stem placement. Circulation. 1994;89:1126-1137.
7. Bourdonnec C, Biron Y, Didier B, Guerin Y, Labrunie P, Lienhard Y, Morice MC, Royer T, Valeix B. Coronary stenting without coumadin. Eur Heart J. 1993;14:350. Abstract.
8. De Caterina R, Sicari R, Bernini W, Lazzerini G, Buti SG, Gianessi D. Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. Thromb Haemost. 1991;65:504-510.
9. Diaz L, Fajadet J, Cassagneau B, Robert G, Marco J. The short-term results and angiographie predictors of subacute thrombosis in the coronary implantation of the Palmaz-Schatz endoprothesis. Rev Esp Cardiol. 1994;47:747-753.
10. Chan CN, Tan AT, Kon TH, Kon P, Lau KW, Gunawan SA, Chakraborty B. Intracoronary stenting in the treatment of acute or threatened closure in angiographically small coronary arteries (<3.0 mm) complicating percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;75:23-25.
11. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, Cleman MW, Cabin HS, Walker C, Stagg J, Buchbinder M, Teirstein PS, Topol EJ, Savage M, Ferez JA, Curry RC, Whithworth H, Sousa JE, Tio F, Almagor Y, Ponder R, Penn IM, Leonard B, Lewine SL, Fish SL, Palmaz JC. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenter study. Circulation. 1991;83:148-161.
12. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, Meier B, Goy JJ, Vogt P, Kappenberger L, Sigwart U. Angiographie follow-up after placement of self-expanding coronary artery stent. N Engl J Med. 1991;324:13-17.
13. Iniguez A, Macaya C, Goicolea J, Alfonso F, Hernandez R, Fernandez R, Suva JC, Zarco P. Angiographic and clinical factors related to subacute Palmaz-Schatz stent occlusion in native vessels: a prospective study. Eur Heart J. 1993;14:323.
14. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione G, Goldberg SL, Tobis SL. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
15. Parsson H, Cwikiel W, Johansson K, Swartbol P, Norgren L. Deposition of platelets and neutrophils in porcine iliac arteries after angioplasty and Wallstent placement compared with angioplasty alone. Cardiovasc Intervent Radiol. 1994;17:190-196.
16. Kopp DT, Tio FO, Ciaravinao V, Schatz RA, Rees C, Alvaredo R, Lancaster JL, Borchert RD. Balloon expandable intra-arterial stents: effects of antithrombotic medication on thrombus formation. In: Zeitler E, ed. Pros and Cons in PTA and Auxilliary Methods, Berlin, Germany: Springer-Verlag; 1989:170-178.
17. Barragan P, Sainsous J, Silvestri M, Bouvier JL, Comet B, Simeoni JB, Charmasson C, Bremondy M. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn. 1995;32:133-138.
18. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989; 1:1215-1220.
19. Cattaneo M, Akkawat B, Lecchi A, Cimminiello C, Capitanio AM, Mannucci PM. Ticlopidine selectively inhibits human platelet response to adenosine diphosphate. Thromb Haemost. 1991;66: 694-699.
20. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R, Fajadet J, Gaspard P, Glatt B, Joly P, Labrunie P, Lienhart Y, Marco J, Petiteau PY, Royer T, Valeix B. Intracoronary stenting without coumadin: 1-month results of a French multicenter study. Cathet Cardiovasc Diagn. 1995;35:1-7.
21. Oweida SW, Roubin GS, Smith RB III, Salam AA. Posteatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vase Surg. 1990;12:310-315.
22. McCann RL, Schwartz LB, Pieper KS. Vascular complications of cardiac catheterization. J Vasc Surg. 1991;14:375-381.
23. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interrventional procedures. Am J Cardiol. 1992;69:63-68.
24. Berge PG, Winter UJ, Hoffmann M, Albrecht D, Hopp HW, Hilger HH. Local vascular complications in heart catheter studies. Z Kardiol. 1993;82:449-456.
25. Popma JJ, Satler LF, Pichard A, Kent KM, Campbell A, Chuang YC, Clark C, Merritt AJ, Bucher TA, Leon MB. Vascular complications after balloon and new device angioplasty. Circulation. 1993;88: 1569-1578.